What Happened?
, -based Appointed Ian Hambelton as Associate Director of Information Technology Security and Network
About the Company
Replimune is creating a new class of oncolytic immunotherapy designed to ignite a powerful immune response to treat cancer and vaccinate against future relapse. Replimune`s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response. Replimune is pioneering the development of novel tumor-directed oncolytic immunotherapies. We imagine a world where cancer is a curable disease.
About the Person
Ian Hambelton is Associate Director of Information Technology Security and Network at . Previously, Ian held various senior IT leadership roles in the industry.
Info Source
News
Short Profile